I don’t think we were advocating leaving money on the sidelines for that reason—patient philanthropy is largely a different argument.
I think that we buy down the 10x interventions, then the 9x, 8x, etc. But even if they are not known, discovering those interventions may possible without the same level of investment in RCTs.
I don’t think we were advocating leaving money on the sidelines for that reason—patient philanthropy is largely a different argument.
I think that we buy down the 10x interventions, then the 9x, 8x, etc. But even if they are not known, discovering those interventions may possible without the same level of investment in RCTs.